Colossal Biosciences has just had a major breakthrough in its attempt to revive the dodo bird from extinction. What are the ...

Discover why the Netherlands is a leading hub for biotech clinical trials, with unique advantages, challenges, and strong ...

The paper mill was discovered by the research-integrity sleuth and scientist Anna Abalkina at the Free University of Berlin ...

The WHO has added GLP-1 agonists to its Essential Medicines List in 2025. Learn more about the impact of this decision.

At the European Cell & Gene Therapy Summit 2025, funding challenges and innovation drove discussions on the sector’s future.

Gene therapies have seen a drop in investor interest lately. Despite this, Kriya Therapeutics seems to be attracting funds in the space.

A couple of months ago, we covered two big funding rounds in the span of two days in radiopharma, Nuclidium’s and Actithera’s. Fast forward to today, and the field is showing absolutely no sign of ...

First, let’s take a look at the private biotech investments in August 2025, breaking them down by value, location, funding type, and therapeutic subsector. In August 2025, not only did gene therapy ...

Green Day once sang, ‘Wake Me Up When September Ends,’ but September isn’t a month to sleep through. It is Blood Cancer Awareness Month, and while it might not be the type of cancer that receives the ...

Two months after ExCellThera’s Zemcelpro (UM171 cell therapy) received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), the European ...